Skip to content
Review

Pretreatment MRI-defined necrotic nodal phenotypes identify distant metastasis risk heterogeneity in N3 nasopharyngeal carcinoma.

Sep 2026 · Oral Oncology · Vol 182, pp. 108135 · 1 citation · 26 references
Medicine

TL;DR

Pretreatment MRI-defined necrotic nodal phenotypes provide additional risk stratification beyond LNN alone and may identify a subgroup of N3 NPC patients with increased risk of distant metastasis.

Abstract

Background

Distant metastasis remains a major cause of treatment failure in nasopharyngeal carcinoma (NPC) treated with definitive intensity-modulated radiotherapy (IMRT), particularly among patients with advanced nodal disease. Although lymph node necrosis (LNN) is an adverse imaging feature, its prognostic significance may vary according to accompanying nodal characteristics.

Methods

This retrospective cohort study included 800 patients with newly diagnosed node-positive non-metastatic NPC treated with definitive IMRT between 2016 and 2023. Pretreatment MRI was reviewed for LNN-related features, including radiologic extranodal extension (rENE), necrotic nodal burden, and anatomic distribution. Associations with distant metastasis-free survival (DMFS) were assessed using Cox regression and overlap weighting.

Results

Among 800 patients, 450 (56.3%) had LNN. After overlap weighting, LNN remained independently associated with inferior DMFS (5-year DMFS, 87.0% vs. 94.2%; weighted HR, 2.26; 95% CI, 1.24-4.12; P = 0.008). Among patients with LNN, severe rENE, higher necrotic nodal burden, and multi-area necrosis were associated with increased metastatic risk. The predefined adverse necrotic nodal phenotype did not further stratify N2 disease but identified significant heterogeneity within N3 disease, with inferior DMFS in N3b compared with N3a patients (HR, 2.52; 95% CI, 1.18-5.39; P = 0.017).

Conclusions

Pretreatment MRI-defined necrotic nodal phenotypes provide additional risk stratification beyond LNN alone and may identify a subgroup of N3 NPC patients with increased risk of distant metastasis. These findings require external validation before clinical implementation.

View source

Similar papers

Open access Nov 2026

MRI-Derived Lymph Node Characteristics for Risk Stratification of Distant Metastasis in Locoregionally Advanced Nasopharyngeal Carcinoma.

BACKGROUND MRI-derived nodal features may improve prognostication beyond TNM staging, but distant-metastasis risk models remain limited. PURPOSE To develop and internally validate an MRI model for distant metastasis prediction in locoregionally advanced nasopharyngeal carcinoma (LA-NPC). STUDY TYPE Retrospective....

Jing Wang, Yu-Xing Yu, Hong-Hong Zhang et al. · 1 citation
Sep 2026

Prognostic Impact of Bulky Lymph Node Metastasis in Thoracic Esophageal Squamous Cell Carcinoma: A Multicenter Cohort Study.

After additional adjustment for cT, cN, and cM, bulky status was no longer significantly associated with DFS or OS and did not improve model fit, but its incremental prognostic value beyond cTNM staging appears limited.

Guo-Qing Zhang, Kang-Hua Zhang, Chang Yuan et al. · 1 citation
Open access Sep 2026

Risk stratification for distant metastasis after postoperative (chemo)radiotherapy in head and neck squamous cell carcinoma.

With the emergence of immune checkpoint inhibitors for resectable locally advanced head and neck squamous cell carcinoma (HNSCC), identifying patients most likely to experience distant relapse after standard postoperative treatment has become increasingly important. The purpose of this study was to evaluate recurrence...

Midori Yui, Yuhei Koike, Satoaki Nakamura et al. · 0 citations
Review Open access Sep 2026

Oncological impacts of lymph node dissection in intrahepatic cholangiocarcinoma with preoperative radiologically negative lymph node metastasis.

Backgrounds/Aims The oncological benefit of lymph node dissection (LND) in intrahepatic cholangiocarcinoma (iCCA) without radiological evidence of nodal metastasis remains uncertain. We evaluated the impact of LND on survival in patients with clinically node-negative (cN0) iCCA. Methods We retrospectively reviewed 27...

Sunghae Park, Kyeongdeok Kim, S. Gwon et al. · 0 citations
Sep 2026

Metastatic Lymph Node Station Count and Risk of First Distant Metastasis After Neoadjuvant Therapy in Esophageal Squamous Cell Carcinoma.

BACKGROUND After neoadjuvant therapy for esophageal squamous cell carcinoma, pathologic nodal staging counts metastatic nodes without capturing their anatomic distribution and is susceptible to stage migration. We evaluated whether involved lymph node station count improves 3-year distant metastasis prediction beyond c...

Jia-Huang Hong, Pei-Yuan Wang, Xiao-Yong Liu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.